Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan P Venook

Showing results (141-150 of 246) with videos related to

Pageof 25
Sort By:
Journal of Gastrointestinal Cancer|July 31, 2018
Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment InitiationMarissa B Savoie, Alan Paciorek, Li Zhang, et al.
JHEP Reports : Innovation in Hepatology|March 14, 2026
Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunctionBridget P Keenan, Zenghua Fan, Bryan Khuong Le, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2015
NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling SurveysRazelle Kurzrock, A Dimitrios Colevas, Anthony Olszanski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2020
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic CancerAndrew H Ko, Alexander C Jordan, Evan Tooker, et al.
JMIR Cancer|January 11, 2022
Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II)Erin L Van Blarigan, Anand Dhruva, Chloe E Atreya, et al.
JCI Insight|June 26, 2019
RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancerOghenekevwe M Gbenedio, Caroline Bonnans, Delphine Grun, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2026
Sex differences in efficacy and toxicity of first-line treatment of metastatic colorectal cancer: An analysis of 18,041 patients in the ARCAD CRC databaseAnna Dorothea Wagner, Morteza Raeisi, Manel Rakez, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
Shifts in the human gut microbiome during cancer chemotherapy are diet-dependentKai R Trepka, Erin L Van Blarigan, Than S Kyaw, et al.
JNCI Cancer Spectrum|April 25, 2025
Associations between early tumor shrinkage/depth of response and survival from the ARCAD databaseHideaki Bando, Yuriko Takeda, Toshihiro Misumi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumorsAdil I Daud, Michelle T Ashworth, Jonathan Strosberg, et al.
Pageof 25

Showing results (141-150 of 246) with videos related to

Sort By:
Pageof 25
Journal of Gastrointestinal Cancer|July 31, 2018
Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment InitiationMarissa B Savoie, Alan Paciorek, Li Zhang, et al.
JHEP Reports : Innovation in Hepatology|March 14, 2026
Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunctionBridget P Keenan, Zenghua Fan, Bryan Khuong Le, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2015
NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling SurveysRazelle Kurzrock, A Dimitrios Colevas, Anthony Olszanski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2020
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic CancerAndrew H Ko, Alexander C Jordan, Evan Tooker, et al.
JMIR Cancer|January 11, 2022
Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II)Erin L Van Blarigan, Anand Dhruva, Chloe E Atreya, et al.
JCI Insight|June 26, 2019
RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancerOghenekevwe M Gbenedio, Caroline Bonnans, Delphine Grun, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2026
Sex differences in efficacy and toxicity of first-line treatment of metastatic colorectal cancer: An analysis of 18,041 patients in the ARCAD CRC databaseAnna Dorothea Wagner, Morteza Raeisi, Manel Rakez, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
Shifts in the human gut microbiome during cancer chemotherapy are diet-dependentKai R Trepka, Erin L Van Blarigan, Than S Kyaw, et al.
JNCI Cancer Spectrum|April 25, 2025
Associations between early tumor shrinkage/depth of response and survival from the ARCAD databaseHideaki Bando, Yuriko Takeda, Toshihiro Misumi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumorsAdil I Daud, Michelle T Ashworth, Jonathan Strosberg, et al.
Pageof 25